Vox Markets Logo

PHP makes third offer for Assura at £1.68bn, trumps KKR and Stonepeak

14:16, 16th May 2025
Vox News
Company News
TwitterFacebookLinkedIn

Primary Health Properties said on Friday that it has made a third takeover offer for Assura valuing the group at £1.68bn, trumping the £1.61bn offer from investment firms KKR and Stonepeak Partners that Assura accepted last month.
The latest offer of 51.7p per share is a 38.2% premium to the closing share price on 13 February, the last business day prior to the start of the offer period. Assura has already rejected offers of 46.2p and 43p a share from PHP.

Primary Health chief executive Mark Davies said: "Our offer announced today enables the shareholders in PHP and Assura to benefit from the rising demand for primary care. The enhanced financial strength of a larger REIT, which is committed to maintaining a strong investment grade credit rating, and is expected to have a reduced cost of capital and annualised cost synergies of approximately £9m.

"The benefits of a combination of PHP and Assura are compelling and set out above. We have carefully crafted our offer which is expected to deliver earnings accretion to both sets of shareholders, underpinning our progressive dividend policy in the future, which remains crucially important. We encourage shareholders to support the combination and look forward to capturing the significant opportunity to create shareholder value in the future from the combined entity."

Assura announced in April that it had agreed to be taken over by KKR and Stonepeak for 49.4p a share, which is a 33.5% premium to the closing price on 13 February.

Assura CEO Jonathan Murphy said at the time: "The cash offer from KKR and Stonepeak offers an attractive opportunity for Assura shareholders to crystallise value immediately."

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist